3.2 Effect of use of ACEi/ARB in patients with COVID-19 on death
(Figure 3)
There was a statistically significant 43%
(95% CI: 0.37-0.88,
I2=0.000) reduction in the odds of death in the
patients on ACEi/ARB when compared to those not on ACEi/ARB. There was
negligible heterogeneity.